https://www.selleckchem.com/pr....oducts/cdk2-inhibito
The PGT-A aneuploid diagnosis clinical error rate was 0%. There was no difference in sustained implantation between the study group and an age-matched control group, where biopsy was not performed (47.9% vs. 45.8). The PGT-A assay evaluated was highly prognostic of failure to deliver when an aneuploid result was obtained. Additionally, the trophectoderm biopsy had no detectable adverse impact on sustained implantation. NCT02032264 and NCT03604107. NCT02032264 and NCT03604107.The COVID-19 pandemic poses a challenge to the manag
Like
Comment
Share
